» Articles » PMID: 22477592

A Comparative Study of Restenosis Rates in Bare Metal and Drug-eluting Stents

Overview
Journal Int J Angiol
Date 2012 Apr 6
PMID 22477592
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Various studies have been performed throughout the world on the rate of restenosis using bare metal stents (BMS) and drug-eluting stents (DES). The prohibitive costs associated with DES generally dictate the type of stent used, especially in developing countries. Therefore, there was a need for a study to assess the effect of various risk factors on restenosis in BMS and DES in the Indian context. A study was performed in the premier institution of the Indian Armed Forces, the Army Hospital (Research and Referral), New Delhi, India, under the aegis of the Indian Council of Medical Research (New Delhi). The profile of patients in the armed forces is inherently diverse in terms of demography, ethnicity, genetics, etc, which reflects the diverse and varied nature of the population in India.

Methods And Results: A total of 130 patients were included in the present study. Follow-up after stent implantation was scheduled for six to nine months following the procedure to assess symptoms, drug compliance, and treadmill test and coronary angiography results, and to ascertain the incidence of restenosis. However, only 80 patients returned for follow-up and, therefore, the final analysis was based on these patients. They were segregated into BMS (n=41) and DES (n=39) groups. Restenosis occurred in 29 patients (36.3%). Nine of 39 patients with DES (23.1%) and 20 of 41 patients with BMS (48.8%) developed restenosis. There was a statistically significant relationship between restenosis and female sex, clinical presentation before intervention and at the time of follow-up evaluation (unstable angina), hypertension, positive stress test and compliance with medical therapy (P<0.05). No statistically significant relationship was observed between restenosis and age, diabetes, smoking, obesity and diet (P>0.05).

Conclusions: DES appear to reduce the restenosis rate and clinical end points, and appear to be more cost effective than BMS. Patient-related factors (eg, sex, hypertension and unstable angina) are important variables that affect the restenosis rate. Noninvasive stress testing had high positive and negative predictive values. Therefore, based on the present study, noninvasive stress testing is suggested before routine angiography at follow-up, which will reduce the need for repeat coronary angiography.

Citing Articles

Investigation of 3D Printed Bioresorbable Vascular Scaffold Crimping Behavior.

Collins C, Leng J, Fu R, Ding Y, Ameer G, Sun C Adv Mater Technol. 2024; 9(8).

PMID: 39247925 PMC: 11376437. DOI: 10.1002/admt.202301698.


A risk score for predicting in-stent restenosis in patients with premature acute myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stent.

Liu S, Yang H, Liu C, Liu Z, Hou J, Wei M Heliyon. 2024; 10(13):e34077.

PMID: 39055837 PMC: 11269898. DOI: 10.1016/j.heliyon.2024.e34077.


Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.

Xi H, Liu J, Xu T, Li Z, Mou X, Jin Y Front Cardiovasc Med. 2023; 10:1117915.

PMID: 36970340 PMC: 10035367. DOI: 10.3389/fcvm.2023.1117915.


Fully implantable batteryless soft platforms with printed nanomaterial-based arterial stiffness sensors for wireless continuous monitoring of restenosis in real time.

Herbert R, Elsisy M, Rigo B, Lim H, Kim H, Choi C Nano Today. 2023; 46.

PMID: 36855693 PMC: 9970263. DOI: 10.1016/j.nantod.2022.101557.


Nano-embedded medical devices and delivery systems in interventional radiology.

San Valentin E, Barcena A, Klusman C, Martin B, Melancon M Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 15(1):e1841.

PMID: 35946543 PMC: 9840652. DOI: 10.1002/wnan.1841.


References
1.
Hermans W, Rensing B, Kelder J, de Feyter P, Serruys P . Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol. 1992; 69(3):194-200. DOI: 10.1016/0002-9149(92)91304-m. View

2.
Aronson D, Bloomgarden Z, Rayfield E . Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 1996; 27(3):528-35. DOI: 10.1016/0735-1097(95)00496-3. View

3.
Lange H, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K . Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004; 350(26):2673-81. DOI: 10.1056/NEJMoa032845. View

4.
Azpitarte J, Tercedor L, Melgares R, Prieto J, Romero J, Ramirez J . The value of exercise electrocardiography testing in the identification of coronary restenosis: a probability analysis. Int J Cardiol. 1995; 48(3):239-47. DOI: 10.1016/0167-5273(94)02240-j. View

5.
Gilbert J, Raboud J, Zinman B . Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting. Diabetes Care. 2004; 27(4):990-4. DOI: 10.2337/diacare.27.4.990. View